Arteris Inc (AIP) fair value: what the stock is really worth
We calculate from audited financials what Arteris Inc is really worth. The fair value tells you whether the price is too high or too low, the quality score (0 to 100) how solid the business behind it is. 26 models, 37 quality factors, updated daily.
Structural break:
The valuation model sees a lasting decline in earnings power for this stock, the confidence band is broken. Treat the target with caution.
Weakest SetupStrongly overvalued and low quality.
!Fair value $2.73 · Strongly overvalued (−88%)
!Quality 49/100
!Mixed Growth(revenue 5y +17.3 %/yr)
!Loss-making · -44.9% net margin (TTM)
✓Negative equity (buybacks among others) · generates free cash flow
!Trails peers(2/9)
!Narrow moat15/100
!Insider activity40/100
!Evidence only low, so the estimate is less certain
Watch Arteris Inc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for free
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 13, 2026.
How to read this chart
58‑month range $3.36 – $48.59 · fair‑value band $1.85 – $4.01 · the $22.69 price screens above the $2.73 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 13, 2026.
Arteris, Inc., together with its subsidiaries, provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East. It manages on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets.
Show more
Arteris, Inc., together with its subsidiaries, provides semiconductor system intellectual property (IP) solutions in the United States, rest of the Americas, China, Korea, the rest of the Asia Pacific, Europe, and the Middle East. It manages on-chip communications and IP block deployments in System-on-Chip (SoC) semiconductors and systems of chiplets. The company offers Network-on-Chip (NoC) IP Products, such as FlexGen, FlexNoC, and FlexWay, a non-coherent NoC IP; Ncore, a cache-coherent NoC IP; and CodaCache, a last-level cache. It also provides hardware security verification software products, such as Cycuity Radix-S to detect and remediate security issues in IP blocks and subsystems of an SoC; Cycuity Radix-M for hardware security verification emulation for system-level SoC and firmware; and Cycuity Radix-ST, a static security analyzer that identifies potential design weaknesses early in the development lifecycle, as well as SoC integration automation software solutions products, including Magillem Connectivity and Registers, and CSRCompiler. In addition, the company offers professional services, such as training, design assistance, and consulting; licensing services for software and intellectual properties; IP support and maintenance; and on-site support services. It serves the automotive, communications, enterprise computing, consumer electronics, and industrial markets. Arteris, Inc. was founded in 2003 and is headquartered in Campbell, California.
Stock analysis
Arteris Inc (AIP) currently trades at $22.69, while our model-based Fair Value estimate is $2.73, implying the stock looks roughly 731.3% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of $3.10 per share, and 0 of the 8 models we run sit above the $22.69 price.
Bear case: the Dividend Discount group reads lowest at $0.6800, and 8 of the 8 models stay below the price. Evidence for this calculation is low.
Scenario range: $1.85 (bear) to $4.01 (bull), the price of $22.69 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 49/100 (below-average quality), in the Technology sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Arteris Inc reported revenue of $70.6M in FY2025 versus $37.9M in FY2021, a compound +16.8%/yr. Reported net income was −$34.7M in FY2025.
Key figures
Market cap $2.0B · P/S ratio 26.6 · EPS (TTM) $−0.7900 · Dividend yield 0.1% · Net margin −49.2% · Return on equity −1,370% · Return on assets (EBIT) −27.2% · Operating margin −38.0%.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 48 out of 100 (low confidence).
What moves the price
The share trades about 50% below its 52-week high and 180% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Technology peers we cover trades at −66% fair-value upside, at −88%, AIP screens richer than that median.
Fair Value models
Bear $1.85Fair Value $2.73Bull $4.01
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+22.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+11.9%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+17.3%
Revenue growth 6 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+14.4%
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−11.9% (2020) → −47.0% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
A lot of optimism in the price
The price assumes more growth than the company has delivered so far and more than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+60.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+19.9%
Yearly sales growth analysts expect, extended to five years.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Semiconductors · 338 stocks
Beats the industry median on 1/9 measures
Overall it trails its industry peers.
Valuation
Quality Score47 · Below median
Fair Value upside−91% · Bottom 25%
Profitability
Return on assets−18% · Bottom 25%
Net margin (TTM)−45% · Bottom 25%
Operating margin (TTM)−38% · Bottom 25%
Growth and dividend
Revenue growth39% · Top 25%
Dividend yield (TTM)0.1% · Bottom 25%
Valuation Multiplesvs Semiconductors median · lower = cheaper
P/S (TTM)26.58× · Priciest 25%
P/FCF382.9× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 0
FUTURE (revenue growth)100· sector 64
PAST (return on equity)0· sector 24
HEALTH (low debt)100· sector 96
DIVIDEND (yield)0· sector 18
VALUE 0: the price sits above our fair-value range.
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Arteris Inc Fair Value". https://www.fairvalue-calculator.com/stock/AIP
Frequently asked questions
Is Arteris Inc (AIP) overvalued or undervalued?
As of Sep 13, 2026, our model estimates a fair value of $2.73 versus a price of $22.69, about −88% upside (overvalued).
What is the fair value of AIP?
Our model-based fair value for Arteris Inc is $2.73 (as of Sep 13, 2026), built from audited fundamentals. The current price: $22.69.
What is the quality score of AIP?
Arteris Inc has a Quality Score of 49/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Arteris Inc (AIP)?
Our model-based price target is the fair value of $2.73 (as of Sep 13, 2026) from 8 valuation models. Cautious scenario $1.85, optimistic scenario $4.01. It is a calculation from audited fundamentals, not an analyst target.
What is the Arteris Inc stock forecast for 2026?
Our models put fair value at $2.73, about −88% upside versus a price of $22.69 (overvalued). Cautious scenario $1.85, optimistic scenario $4.01. The calculation is refreshed regularly with new filings.
What is the revenue of Arteris Inc (AIP)?
Arteris Inc reported trailing-twelve-month revenue of about $77.0M (latest available figure, as of Sep 13, 2026).
Does Arteris Inc pay a dividend?
Arteris Inc currently shows a dividend yield of about 0.10% relative to its recent price (as of Sep 13, 2026).
What growth is priced into Arteris Inc (AIP)?
For today's price to be fair in a discounted-cash-flow model, Arteris Inc would have to grow free cash flow by +60.8 % per year for five years (discount rate 12.1 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +17.3 % per year. As of Sep 13, 2026.
What discount rate (WACC) does the fair value of AIP use?
Our models discount Arteris Inc at 12.1 %: a base by market capitalisation (mid), damped by beta 1.99, country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Arteris Inc that is +60.8 % per year a year over ten years, using the same discount rate (12.1 %) and the same formula as our fair value.
How much growth has Arteris Inc (AIP) delivered so far?
Over the past 5 years revenue at Arteris Inc grew +17.3 % a year. The price currently implies +60.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Arteris Inc (AIP) growing?
The median revenue growth in the sector is +8.1 % a year. That is the yardstick for the growth priced into Arteris Inc (+60.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Arteris Inc (AIP)?
The free-cash-flow yield on the price is 0.56 %: that much free cash flow Arteris Inc produces per unit of market value. When it exceeds the discount rate of our models (12.1 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Arteris Inc (AIP)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Arteris Inc it is $2.73 per share (as of Sep 13, 2026), against a price of $22.69. It is the blended result of 8 valuation models (cash flow, earnings, asset, dividend).
Is Arteris Inc stock overvalued or undervalued in 2026?
As of Sep 13, 2026, AIP trades above its calculated fair value: price $22.69, fair value $2.73, a gap of about −88% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of AIP?
No. The price is what the market pays today ($22.69); the fair value is what the company's own numbers justify ($2.73). For Arteris Inc the two are $19.96 per share apart. That gap is exactly why we show both numbers side by side.
How much is Arteris Inc worth?
The market values Arteris Inc at about $2.0B (market capitalisation, as of Sep 13, 2026). Per share that is $22.69; our models calculate a fair value of $2.73 per share.
What do the bullish and bearish scenarios say about AIP?
Our models span a range for Arteris Inc: cautious scenario $1.85, base $2.73, optimistic $4.01 per share (as of Sep 13, 2026, price $22.69). The range comes from different growth and margin assumptions, not from analyst opinions.
How far is AIP from its 52-week high?
Arteris Inc trades at $22.69, about 50% below its 52-week high of $44.94 and 180% above the low of $8.10 (as of Sep 13, 2026). Distance from the high says nothing about value: that is what the fair value of $2.73 is for.
Which stocks are comparable to Arteris Inc?
From the same area (Technology) we also value NVIDIA Corporation, Taiwan Semiconductor Manufacturing Company, Broadcom Inc, SK hynix Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Arteris Inc stock attractive at the current price?
The data as of Sep 13, 2026: price $22.69, calculated fair value $2.73 (−88%), Quality Score 49/100, from 8 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of AIP calculated?
We run Arteris Inc through 8 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $2.73, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.8 % above its aggregate fair value. Arteris Inc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What should I pay attention to with Arteris Inc right now?
The price sits above even our optimistic bull case ($4.01). The favourable scenario is already priced in. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. Solid but not exceptional quality (49/100) and above fair value, neither a clear bargain nor a standout compounder. A fairly wide model range ($1.85 to $4.01) leaves room in how you read the outcome.
Key figures of Arteris Inc
How large is the market capitalisation of Arteris Inc (AIP)?
The market capitalisation of Arteris Inc is $2.0B. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Arteris Inc (AIP)?
The price-to-sales ratio of Arteris Inc is 26.6 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Arteris Inc (AIP)?
Earnings per share at Arteris Inc are $−0.7900. Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Arteris Inc (AIP)?
The dividend yield of Arteris Inc is 0.1%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Arteris Inc (AIP)?
The net margin of Arteris Inc is −49.2% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Arteris Inc (AIP)?
The return on equity (ROE) of Arteris Inc is −1,370% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Arteris Inc (AIP)?
On an EBIT basis the return on assets of Arteris Inc is −27.2% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Arteris Inc (AIP)?
The operating margin of Arteris Inc is −38.0% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Arteris Inc (AIP)?
Revenue at Arteris Inc is growing +38.7% versus a year earlier (3y avg +11.9%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much net cash does Arteris Inc (AIP) hold?
Arteris Inc holds more cash than debt, $24.8M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Arteris Inc in the live analysis
One click puts Arteris Inc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 13, 2026